Friday, 24 February 2012

Basal Cell Carcinoma-Skin Cancer

US approves new drug for common skin cancer
Symptoms Of Skin Cancer-Metastatic Melanoma
Erivedge (vismodegib) is made by Genentech, a US subsidiary of the Swiss drug giant Roche

US authorities on Monday approved a new drug to treat the most common form of skin cancer, basal cell carcinoma, which is rarely lethal but can spread if left untreated. read more..

No comments:

Post a comment